Summary
Fewer than half of the world’s infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.
English 
Spanish 
French 
Russian 
Arabic